Ireland - English - HPRA (Health Products Regulatory Authority)

curium netherlands b.v. - tetrakis (2-methylopropyl-isocyanide) copper (i) tetrafluoroborate - kit for radiopharmaceutical preparation - 1 milligram(s) - technetium (99mtc) sestamibi

Malta - English - Malta Medicines Authority

curium netherlands b.v westerduinweg 3, 1755 le petten, netherlands - tetrakis, methoxy isobutyl, isonitrile, copper, tetrafluorolborate - kit for radiopharmaceutical preparation - tetrakis (2-methoxy isobutyl isonitrile) copper (i) tetrafluorolborate 1 mg - diagnostic radiopharmaceuticals

Malta - English - Malta Medicines Authority

institute of isotopes co. ltd h-1121 budapest, konkoly-thege miklós út 29-33, hungary - tetrakis, methoxy isobutyl, isonitrile, copper, tetrafluorolborate - kit for radiopharmaceutical preparation powder for solution for injection - tetrakis (2-methoxy isobutyl isonitrile) copper (i) tetrafluorolborate 1 mg - diagnostic radiopharmaceuticals

United States - English - NLM (National Library of Medicine)

lantheus medical imaging, inc. - tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate (unii: n6ou7hj70p) (tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate - unii:n6ou7hj70p) - tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate 1 mg in 1 ml - myocardial imaging: technetium tc99m sestamibi is a myocardial perfusion agent that is indicated for detecting coronary artery disease by localizing myocardial ischemia (reversible defects) and infarction (non-reversible defects), in evaluating myocardial function and developing information for use in patient management decisions. technetium tc99m sestamibi evaluation of myocardial ischemia can be accomplished with rest and cardiovascular stress techniques (e.g., exercise or pharmacologic stress in accordance with the pharmacologic stress agent's labeling). it is usually not possible to determine the age of a myocardial infarction or to differentiate a recent myocardial infarction from ischemia. breast imaging: technetium tc99m sestamibi is indicated for planar imaging as a second line diagnostic drug after mammography to assist in the evaluation of breast lesions in patients with an abnormal mammogram or a palpable breast mass. technetium tc99m sestamibi is not indicated for breast cancer screening, to co

United States - English - NLM (National Library of Medicine)

lantheus medical imaging, inc. - tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate (unii: n6ou7hj70p) (tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate - unii:n6ou7hj70p) - tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate 1 mg in 1 ml - myocardial imaging: cardiolite® , kit for the preparation of technetium tc99m sestamibi for injection, is a myocardial perfusion agent that is indicated for detecting coronary artery disease by localizing myocardial ischemia (reversible defects) and infarction (non-reversible defects), in evaluating myocardial function and developing information for use in patient management decisions. cardiolite® evaluation of myocardial ischemia can be accomplished with rest and cardiovascular stress techniques (e.g., exercise or pharmacologic stress in accordance with the pharmacologic stress agent's labeling). it is usually not possible to determine the age of a myocardial infarction or to differentiate a recent myocardial infarction from ischemia. breast imaging: miraluma® , kit for the preparation of technetium tc99m sestamibi for injection, is indicated for planar imaging as a second line diagnostic drug after mammography to assist in the evaluation of breast lesions in patients with an abnormal mammogram or a palpa

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

cis bio international - copper tetramibi tetrafluoroborate 1 mg - kit for radiopharmaceutical preparation - 1 mg - tetrakis (2-methoxy-2-methylpropyl-1-isocyanide) copper (i) tetrafluoroborate 1 mg - technetium (99mtc) sestamibi

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

curium netherlands b.v. - copper tetramibi tetrafluoroborate 1 mg - kit for radiopharmaceutical preparation - 1 mg - tetrakis (2-methoxy-2-methylpropyl-1-isocyanide) copper (i) tetrafluoroborate 1 mg - technetium (99mtc) sestamibi

Malta - English - Malta Medicines Authority

radiopharmacy laboratory ltd 2040 budaörs, gyár u. 2 , hungary - kit for radiopharmaceutical preparation - tetrakis (2-methoxy isobutyl isonitrile) copper (i) tetrafluorolborate 0.5 mg - diagnostic radiopharmaceuticals

United States - English - NLM (National Library of Medicine)

anazaohealth corporation - tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate (unii: n6ou7hj70p) (tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate - unii:n6ou7hj70p) - tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate 1.5 mg - sestamibi is a diagnostic agent used to assess areas of reversible myocardial ischemia in the presence or absence of infracted myocardium. evaluation of myocardial ischemia can be accomplished with rest and cardiovascular stress techniques.

Ireland - English - HPRA (Health Products Regulatory Authority)

cis bio international - tetrakis (2-methoxy isobutyl isonitrile) copper (i) tetrafluorolborate - kit for radiopharmaceutical preparation - 1 milligram(s) - technetium (99mtc) compounds; technetium (99mtc) sestamibi